Douglas Cartwright

2.3k total citations
13 papers, 33 citations indexed

About

Douglas Cartwright is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Douglas Cartwright has authored 13 papers receiving a total of 33 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Surgery and 3 papers in Cancer Research. Recurrent topics in Douglas Cartwright's work include PARP inhibition in cancer therapy (3 papers), Breast Cancer Treatment Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). Douglas Cartwright is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), Breast Cancer Treatment Studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). Douglas Cartwright collaborates with scholars based in United Kingdom, Finland and United States. Douglas Cartwright's co-authors include Laura E. Crotty Alexander, Caroline Kelly, Selina Tsim, Matthew Evison, Jayne Holme, Kevin G. Blyth, Christopher J. Fong, Lydia Howell, Ewen Ross and Alistair S. McLaren and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Douglas Cartwright

8 papers receiving 32 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas Cartwright United Kingdom	3	23	9	7	5	4	13	33
Alexandra Carmel France	3	25 1.1×	11 1.2×	9 1.3×	6 1.2×		4	34
Agustín Falco Argentina	3	12 0.5×	9 1.0×	8 1.1×	4 0.8×		7	23
Arturo Zapata Peru	3	14 0.6×	12 1.3×	6 0.9×	4 0.8×		3	33
Courtney C. Cavalieri United States	4	13 0.6×	11 1.2×	9 1.3×	3 0.6×		5	24
Jinwook Choi United Kingdom	2	18 0.8×	10 1.1×	6 0.9×	4 0.8×		3	33
Anne Calvaresi United States	3	36 1.6×	6 0.7×	4 0.6×	5 1.0×		8	41
A. Eniu United States	3	18 0.8×	26 2.9×	4 0.6×	10 2.0×		4	35
Alma Blázquez‐Martín Spain	3	7 0.3×	10 1.1×	12 1.7×	3 0.6×		7	24
T. Koike Japan	3	12 0.5×	11 1.2×	4 0.6×	8 1.6×		4	20
Simona Massa Italy	3	23 1.0×	11 1.2×	14 2.0×	2 0.4×	3 0.8×	11	36

Countries citing papers authored by Douglas Cartwright

Since Specialization

Citations

This map shows the geographic impact of Douglas Cartwright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Cartwright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Cartwright more than expected).

Fields of papers citing papers by Douglas Cartwright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Cartwright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Cartwright. The network helps show where Douglas Cartwright may publish in the future.

Co-authorship network of co-authors of Douglas Cartwright

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Cartwright. A scholar is included among the top collaborators of Douglas Cartwright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Cartwright. Douglas Cartwright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Cartwright, Douglas, Mark P. Lythgoe, Alexander K. Smith, et al.. (2025). 1238eTiP Phase I/IIa, open-label, dose finding, safety and exploratory trial of THEO-260: A novel oncolytic immunotherapy, by intravenous delivery in patients with high grade serous or endometrioid ovarian cancer. Annals of Oncology. 36. S747–S747.

Cartwright, Douglas, Alistair S. McLaren, Mark White, et al.. (2025). 109P Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer: The west of Scotland experience. Annals of Oncology. 36. S50–S51.

Cartwright, Douglas, et al.. (2025). Oncogenic Signalling Pathways in Cancer Immunotherapy: Leader or Follower in This Delicate Dance?. International Journal of Molecular Sciences. 26(9). 4393–4393.

Hall, Peter, et al.. (2024). Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective. The Breast. 75. 103728–103728.

McLaren, Alistair S., Douglas Cartwright, Stephen T. Barclay, et al.. (2023). Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study. BMJ Open Gastroenterology. 10(1). e001231–e001231.

Neilson, Lisa J., Douglas Cartwright, Maija Risteli, et al.. (2023). Omentum-derived matrix enables the study of metastatic ovarian cancer and stromal cell functions in a physiologically relevant environment. SHILAP Revista de lepidopterología. 19-20. 100136–100136. 2 indexed citations

Roxburgh, Patricia, Douglas Cartwright, Alistair S. McLaren, et al.. (2023). Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting. Journal of Clinical Medicine. 12(7). 2497–2497. 3 indexed citations

Anderson, Stewart, et al.. (2023). Clinical Experience of Axillary Radiotherapy for Node-positive Breast Cancer. Clinical Oncology. 36(2). 98–106. 1 indexed citations

McLaren, Alistair S., Douglas Cartwright, Ewen Ross, & Patricia Roxburgh. (2021). First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis. SHILAP Revista de lepidopterología. 4(3). 171–174. 4 indexed citations

10.

Cartwright, Douglas, Patricia Roxburgh, Bárbara Stanley, et al.. (2020). 510 Niraparib outcomes in brca wild-type platinum sensitive recurrent ovarian cancer: a comparison of real-world data to the nova trial. A85.3–A86. 1 indexed citations

11.

Cartwright, Douglas, et al.. (2020). 1 Hyperglycaemia in T1DM and pancreatitis related diabetes. Postgraduate Medical Journal. 96(1132). 119–119. 1 indexed citations

12.

Tsim, Selina, Douglas Cartwright, Christopher J. Fong, et al.. (2019). Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy – Data supporting ‘Direct to LAT’ in selected groups. Lung Cancer. 133. 123–129. 19 indexed citations

13.

Cartwright, Douglas & Lydia Howell. (1993). Intraoperative cytology as an elective surgical procedure. Analysis of 57 cases.. PubMed. 37(3). 280–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact